-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 BMJqQI0ZjnkUJRBU6fmf1iUHe4TyZ2zmVDresbM2LIBrLELRrtuoLfm64Zt0AFuX
 Xe7rEEiw9ADzLNC9dJk44w==

<SEC-DOCUMENT>0000950120-04-000694.txt : 20041025
<SEC-HEADER>0000950120-04-000694.hdr.sgml : 20041025
<ACCEPTANCE-DATETIME>20041025170751
ACCESSION NUMBER:		0000950120-04-000694
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20041025
DATE AS OF CHANGE:		20041025
GROUP MEMBERS:		VERUS INTERNATIONAL GROUP LIMITED
GROUP MEMBERS:		VERUS INVESTMENT HOLDINGS, INC.

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KHAN AJMAL
		CENTRAL INDEX KEY:			0001092446

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		LAURISTON HOUSE SUITE 101
		CITY:			ST MICHAEL BARBADOS
		STATE:			C8

	MAIL ADDRESS:	
		STREET 1:		LAURISTON HOUSE SUITE 101
		CITY:			ST MICHAEL BARBADOS
		STATE:			C8

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DIOMED HOLDINGS INC
		CENTRAL INDEX KEY:			0001074874
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				841480636
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-78121
		FILM NUMBER:		041094628

	BUSINESS ADDRESS:	
		STREET 1:		1 DUNDEE PARK
		CITY:			ANDOVER
		STATE:			MA
		ZIP:			01810
		BUSINESS PHONE:		978-475-7771

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NATEXCO CORP
		DATE OF NAME CHANGE:	20001128
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>d624985.txt
<DESCRIPTION>SCHEDULE 13D/A, AMENDMENT #7
<TEXT>
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                  SCHEDULE 13D
                    Under the Securities Exchange Act of 1934
                               (Amendment No. 7)*


                              DIOMED HOLDINGS, INC.
                              ---------------------
                                (Name of Issuer)


                    Common Stock, par value $0.001 per share
                    ----------------------------------------
                         (Title of Class of Securities)


                                    25454R207
                                    ---------
                                 (CUSIP Number)


                                 Mr. Ajmal Khan
                      c/o Verus International Group Limited
                               20 West 55th Street
                            New York, New York 10019
                            ------------------------
          (Name, Address, and Telephone Number of Person Authorized to
                       Receive Notices and Communications)


                                  June 10, 2003
                                  -------------
             (Date of Event which Requires Filing of This Statement)

          If the filing person has previously filed a statement on Schedule 13G
to report the acquisition that is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box. /_/

          Note. Schedules filed in paper format shall include a signed original
     and five copies of the schedule, including all exhibits. See Rule 13d-7 for
     other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the Notes).


<PAGE>


- --------------------------------------------------------------------------------
CUSIP No. 25454R207
- --------------------------------------------------------------------------------
       1        NAME OF REPORTING PERSONS I.R.S.             Ajmal Khan
                IDENTIFICATION NO. OF ABOVE PERSON
- --------------------------------------------------------------------------------
       2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
                                                             (a) |_|
                                                             (b) |X|
- --------------------------------------------------------------------------------
       3        SEC USE ONLY
- --------------------------------------------------------------------------------
       4        SOURCE OF FUNDS     N/A
- --------------------------------------------------------------------------------
       5        CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
                REQUIRED PURSUANT TO ITEM 2(d) or 2(e)
                |_|

- --------------------------------------------------------------------------------
       6        CITIZENSHIP OR PLACE OF ORGANIZATION
                Canada and United Kingdom
- --------------------------------------------------------------------------------

 NUMBER OF           7        SOLE VOTING POWER              1,466,491*
  SHARES        ----------------------------------------------------------------
BENEFICIALLY         8        SHARES VOTING POWER
  OWNED BY      ----------------------------------------------------------------
    THE              9        SOLE DISPOSITIVE POWER         1,466,491*
 REPORTING      ----------------------------------------------------------------
PERSON WITH         10        SHARED DISPOSITIVE POWER

- --------------------------------------------------------------------------------
      11        AGGREGATE AMOUNT BENEFICIALLY OWNED BY       1,466,491*
                THE REPORTING PERSON
- --------------------------------------------------------------------------------
      12        CHECK BOX IF THE AGGREGATE AMOUNT IN ROW     |_|
                (11) EXCLUDES CERTAIN SHARES
- --------------------------------------------------------------------------------
      13        PERCENT OF CLASS REPRESENTED BY AMOUNT
                IN ROW (11)                                  4.9%
- --------------------------------------------------------------------------------
      14        TYPE OF REPORTING PERSON                     IN
- --------------------------------------------------------------------------------
*Through his position as the majority owner of Verus International Group Limited
and Verus Investment Holdings, Inc., Mr. Khan has the power to dispose of or
direct the disposition of the shares of Common Stock. As a result, Mr. Khan may,
under the rules of the Securities and Exchange Commission, be deemed to be the


                                       2
<PAGE>


beneficial owner of the shares of Common Stock. Mr. Khan disclaims beneficial
ownership of the shares of Common Stock reported as beneficially owned by him,
except to the extent of his pecuniary interest therein.


                                       3
<PAGE>


- --------------------------------------------------------------------------------
CUSIP No. 25454R207
- --------------------------------------------------------------------------------
       1        NAME OF REPORTING PERSONS I.R.S.             Verus International
                IDENTIFICATION NO. OF ABOVE PERSON           Group Limited
- --------------------------------------------------------------------------------
       2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
                                                             (a) |_|
                                                             (b) |X|
- --------------------------------------------------------------------------------
       3        SEC USE ONLY
- --------------------------------------------------------------------------------
       4        SOURCE OF FUNDS     N/A
- --------------------------------------------------------------------------------
       5        CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
                REQUIRED PURSUANT TO ITEM 2(d) or 2(e)
                |_|

- --------------------------------------------------------------------------------
       6        CITIZENSHIP OR PLACE OF ORGANIZATION
                British Virgin Islands
- --------------------------------------------------------------------------------

 NUMBER OF           7        SOLE VOTING POWER              125,900
  SHARES        ----------------------------------------------------------------
BENEFICIALLY         8        SHARES VOTING POWER
  OWNED BY      ----------------------------------------------------------------
    THE              9        SOLE DISPOSITIVE POWER         125,900
 REPORTING      ----------------------------------------------------------------
PERSON WITH         10        SHARED DISPOSITIVE POWER

- --------------------------------------------------------------------------------
      11        AGGREGATE AMOUNT BENEFICIALLY OWNED BY       125,900
                THE REPORTING PERSON
- --------------------------------------------------------------------------------
      12        CHECK BOX IF THE AGGREGATE AMOUNT IN ROW     |_|
                (11) EXCLUDES CERTAIN SHARES
- --------------------------------------------------------------------------------
      13        PERCENT OF CLASS REPRESENTED BY AMOUNT
                IN ROW (11)                                  0.4%
- --------------------------------------------------------------------------------
      14        TYPE OF REPORTING PERSON                     CO
- --------------------------------------------------------------------------------


                                    4
<PAGE>


- --------------------------------------------------------------------------------
CUSIP No. 25454R207
- --------------------------------------------------------------------------------
       1        NAME OF REPORTING PERSONS I.R.S.             Verus Investment
                IDENTIFICATION NO. OF ABOVE PERSON           Holdings, Inc.
- --------------------------------------------------------------------------------
       2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
                                                             (a) |_|
                                                             (b) |X|
- --------------------------------------------------------------------------------
       3        SEC USE ONLY
- --------------------------------------------------------------------------------
       4        SOURCE OF FUNDS     N/A
- --------------------------------------------------------------------------------
       5        CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
                REQUIRED PURSUANT TO ITEM 2(d) or 2(e)
                |_|

- --------------------------------------------------------------------------------
       6        CITIZENSHIP OR PLACE OF ORGANIZATION
                British Virgin Islands
- --------------------------------------------------------------------------------

 NUMBER OF           7        SOLE VOTING POWER              1,340,591
  SHARES        ----------------------------------------------------------------
BENEFICIALLY         8        SHARES VOTING POWER
  OWNED BY      ----------------------------------------------------------------
    THE              9        SOLE DISPOSITIVE POWER         1,340,591
 REPORTING      ----------------------------------------------------------------
PERSON WITH         10        SHARED DISPOSITIVE POWER

- --------------------------------------------------------------------------------
      11        AGGREGATE AMOUNT BENEFICIALLY OWNED BY       1,340,591
                THE REPORTING PERSON
- --------------------------------------------------------------------------------
      12        CHECK BOX IF THE AGGREGATE AMOUNT IN ROW     |_|
                (11) EXCLUDES CERTAIN SHARES
- --------------------------------------------------------------------------------
      13        PERCENT OF CLASS REPRESENTED BY AMOUNT
                IN ROW (11)                                  4.5%
- --------------------------------------------------------------------------------
      14        TYPE OF REPORTING PERSON                     CO
- --------------------------------------------------------------------------------


                                       5
<PAGE>


ITEM 1. SECURITY AND ISSUER.

This Amendment No. 7 to the Schedule 13D, dated February 14, 2002, of Diomed
Holdings, Inc., a Delaware corporation (the "Issuer"), is filed to reflect the
information required pursuant to Rule 13d-2 of the Securities and Exchange Act
of 1934, as amended (the "Act"), relating to common shares, $0.001 par value per
share (the "Common Stock") of the Issuer. The Issuer's principal executive
office is 1 Dundee Park, Andover, MA 01810.

ITEM 2. IDENTITY AND BACKGROUND.

(I)  AJMAL KHAN

(a)  This statement is being filed on behalf of Ajmal Khan, an individual and
     majority owner of Verus International Group Limited and Verus Investment
     Holdings, Inc.

(b)  The business address of Mr. Khan is c/o Verus International Group Limited,
     20 West 55th Street, New York, New York 10019.

(c)  Mr. Khan's principal occupation is private investor.

(d)-(e) During the last five years Mr. Khan has not (i) been convicted in a
criminal proceeding (excluding traffic violations or similar misdemeanors); or
(ii) been a party to a civil proceeding of a judicial or administrative body of
competent jurisdiction where as a result of such proceeding was or is subject to
a judgment, decree or final order enjoining future violations of, or prohibiting
or mandating activities subject to federal or state securities laws or finding
any violation with respect to such laws.

(f)  Mr. Khan holds Canadian and United Kingdom citizenships.

(II) VERUS INTERNATIONAL GROUP LIMITED

This statement is being filed on behalf of Verus International Group Limited
("Verus International"), a British Virgin Islands corporation. Verus
International is engaged in investment holdings. The address of Verus
International's principal office is 20 West 55th Street, New York, New York
10019.

(d)-(e) During the last five years no executive officer, director, or control
person of Verus International has (i) been convicted in a criminal proceeding
(excluding traffic violations or similar misdemeanors); or (ii) been a party to
a civil proceeding of a judicial or administrative body of competent
jurisdiction where as a result of such proceeding was or is subject to a
judgment, decree or final order enjoining future violations of, or prohibiting
or mandating activities subject to federal or state securities laws or finding
any violation with respect to such laws.

(III) VERUS INVESTMENT HOLDINGS INC.

This statement is being filed on behalf of Verus Investment Holdings, Inc.
("Verus Investment"), a British Virgin Islands corporation. Verus Investment is
engaged in investment holdings. The address of Verus Investment's principal
office is 20 West 55th Street, New York, New York 10019.


                                       6
<PAGE>


(d)-(e) During the last five years no executive officer, director, or control
person of Verus Investment has (i) been convicted in a criminal proceeding
(excluding traffic violations or similar misdemeanors); or (ii) been a party to
a civil proceeding of a judicial or administrative body of competent
jurisdiction where as a result of such proceeding was or is subject to a
judgment, decree or final order enjoining future violations of, or prohibiting
or mandating activities subject to federal or state securities laws or finding
any violation with respect to such laws.

ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

Not applicable.

ITEM 4. PURPOSE OF TRANSACTION

(I)  AJMAL KHAN

On June 10, 2003, Mr. Khan sold 302,100 shares of Common Stock that he
beneficially owns as the majority owner of Verus Investment through open market
sales.

(II) VERUS INTERNATIONAL GROUP LIMITED

Not applicable.

(III) VERUS INVESTMENT HOLDINGS, INC.

On June 10, 2003, Verus Investment sold 302,100 shares of Common Stock that it
beneficially owns through open market sales.

ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.

(I)  AJMAL KHAN

(a) As of the date of this report, Mr. Khan, through his majority ownership of
Verus International and Verus Investment, beneficially owns an aggregate of
1,466,491 shares of Common Stock, which represents 4.9% of the Issuer's Common
Stock.

(b) As of the date of this report, Mr, Khan has the sole power to vote or direct
the voting of, or dispose or direct the disposition of 1,466,491 shares of the
Issuer's Common Stock.

(c) Mr. Khan has not effected any transactions other than that described herein
in the class of securities described since the most recent filing on Schedule
13D.

(d) Not applicable.

(e) Mr. Khan ceased to be a beneficial owner of more than 5% of the class of
securities described herein on June 10, 2003.

(II) VERUS INTERNATIONAL GROUP LIMITED

(a) As of the date of this report, Verus International, beneficially owns an
aggregate of 125,900 shares of Common Stock, which represents 0.4% of the
Issuer's Common Stock.


                                       7
<PAGE>


(b) As of the date of this report, Verus International has the sole power to
vote or direct the voting of, or dispose or direct the disposition of 125,900
shares of the Issuer's Common Stock.

(c) Verus International has not effected any transaction other in the class of
securities described since the most recent filing on Schedule 13D.

(d) Not applicable.

(e) Verus International ceased to be a beneficial owner of more than 5% of the
class of securities described herein on May 27, 2003.

(III) VERUS INVESTMENT HOLDINGS, INC.

(a) As of the date of this report, Verus Investment, beneficially owns an
aggregate of 1,340,591 shares of Common Stock, which represents 4.5% of the
Issuer's Common Stock.

(b) As of the date of this report, Verus Investment has the sole power to vote
or direct the voting of, or dispose or direct the disposition of 1,340,591
shares of the Issuer's Common Stock.

(c) Verus Investment has not effected any transactions other than that described
herein in the class of securities described since the most recent filing on
Schedule 13D.

(d) Not applicable.

(e) Verus Investment ceased to be a beneficial owner of more than 5% of the
class securities described herein on June 10, 2003.

ITEM 6. CONTRACTS, AGREEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
        SECURITIES OF THE ISSUER

Not applicable.


                                       8
<PAGE>


                               S I G N A T U R E

          After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete, and
correct.

Date:  October 25, 2004                    VERUS INVESTMENT HOLDINGS, INC.


                                           By: /s/ Ajmal Khan
                                               ---------------------------------
                                           Name:  Ajmal Khan
                                           Title: Authorized Representative


                                           VERUS INTERNATIONAL GROUP LIMITED


                                           By: /s/ Ajmal Khan
                                               ---------------------------------
                                           Name:  Ajmal Khan
                                           Title: Authorized Representative


                                           /s/ Ajmal Khan
                                           -------------------------------------
                                           Ajmal Khan

                                       9


<PAGE>


                                                                       EXHIBIT A

               JOINT FILING AGREEMENT PURSUANT TO RULE 13D-1(K)(1)

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as
amended, the undersigned hereby agree to the joint filing on behalf of each of
them of a statement on Schedule 13D Amendment No. 7 (including any additional
amendments thereto) with respect to the Common Stock of Diomed Holdings, Inc.,
and that this Agreement be included as an Exhibit to such joint filing.

IN WITNESS WHEREOF, the undersigned hereby execute this Agreement this 25th day
of October, 2004.


                                           VERUS INVESTMENT HOLDINGS, INC.


                                           By: /s/ Ajmal Khan
                                               ---------------------------------
                                           Name:  Ajmal Khan
                                           Title: Authorized Representative


                                           VERUS INTERNATIONAL GROUP LIMITED


                                           By: /s/ Ajmal Khan
                                               ---------------------------------
                                           Name:  Ajmal Khan
                                           Title: Authorized Representative


                                           /s/ Ajmal Khan
                                           -------------------------------------
                                           Ajmal Khan

                                       i

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
